Sales and usage Bicalutamide
between january 2007 , december 2009 (a period of 3 years), 1,232,143 prescriptions of bicalutamide dispensed in u.s., or 400,000 prescriptions per year. during time, bicalutamide accounted 87.2% of nsaa market, while flutamide accounted 10.5% of , nilutamide 2.3% of it. approximately 96% of bicalutamide prescriptions written diagnosis codes indicated neoplasm. 1,200, or 0.1% of bicalutamide prescriptions dispensed pediatric patients (age 0–16).
Comments
Post a Comment